- Company
- Scripps Research Translational Institute
- Role
- Founder & Director
- Est. Net Worth
- $3 Million (Est.)
- Stage
- Emerging
- Industry
- Healthcare
Eric Topol
Founder & Director at Scripps Research Translational Institute
About
Eric Topol is a cardiologist, geneticist, and digital health visionary who founded the Scripps Research Translational Institute to bridge the gap between genomic discoveries and patient care. He was among the first physicians to champion the use of smartphones, wearables, and AI in medicine, authoring three influential books — 'The Creative Destruction of Medicine,' 'The Patient Will See You Now,' and 'Deep Medicine' — that mapped out how technology would democratize healthcare. Topol led the clinical research that exposed cardiovascular risks of Vioxx, contributing to its withdrawal, and has been named one of the most influential physicians in America by multiple outlets. His institute pioneers clinical trials using digital tools and genomic data.
Current Company
Scripps Research Translational Institute — Founder & Director
The Physician Who Predicted Digital Health
Eric Topol has spent decades at the intersection of cardiology, genomics, and digital health, consistently predicting technological shifts in medicine years before they arrived. His 2012 book 'The Creative Destruction of Medicine' argued that smartphones and genomic sequencing would democratize healthcare, giving patients access to data and diagnostic tools that had previously been locked inside hospitals and labs. At the time, most physicians dismissed the idea. A decade later, the Apple Watch can detect atrial fibrillation, continuous glucose monitors are mainstream, and telehealth visits outnumber in-person visits for many specialties.
Topol's credibility stems from his dual identity as both a practicing cardiologist and a researcher. He led the Cleveland Clinic's cardiology department and later founded the Scripps Research Translational Institute, where he runs clinical trials using wearable sensors, AI diagnostics, and genomic data. His 2019 book 'Deep Medicine' argued that AI could restore the human element in healthcare by automating routine tasks and freeing physicians to spend more time with patients.
Whistleblower and Public Health Voice
Topol's most controversial contribution came in 2004 when his research helped expose the cardiovascular risks of Vioxx, the Merck painkiller that was eventually linked to tens of thousands of heart attacks and strokes. Merck withdrew the drug, and the scandal became one of the largest pharmaceutical safety failures in history. Topol's willingness to challenge a pharmaceutical giant — at professional risk — established his reputation as a physician who prioritizes patient safety over institutional pressure.
During the COVID-19 pandemic, Topol became one of the most trusted scientific voices on social media, translating complex research into accessible commentary for millions of followers. His Substack newsletter 'Ground Truths' continues to be widely read by both medical professionals and the general public. Topol represents a new kind of medical leader — one whose influence comes not from institutional authority but from intellectual credibility built across books, research, and digital communication.